Carl Zeiss Meditec AG (XSWX:AFX) Momentum Rank: 2 (As of Aug. 01, 2026) — 60% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:AFX Carl Zeiss Meditec AG XSWX:AFX
70 GF Score
Price CHF27.56
GF Value CHF66.33
! 3 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG Momentum Rank?

Carl Zeiss Meditec AG XSWX:AFX 70 Momentum Rank is 2 as of Aug. 01, 2026, which is 60% below its 10-year median of 5.00. GuruFocus rates XSWX:AFX with a GF Score™ of 70/100 and a GF Value™ of CHF66.33. The stock has 3 warning signs investors should review.

Carl Zeiss Meditec AG has the Momentum Rank of 2.

Momentum Rank measures the strength and persistence of a stock's price movement over time, rated on a scale of 1 to 10.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

A higher score reflects strong price momentum and indicates greater potential for superior performance. Conversely, a lower score indicates that momentum is either too high or too low, and stocks tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Carl Zeiss Meditec AG Momentum Rank Related Terms

XSWX:AFX vs ISRG, BDX, MDLN: Momentum Rank Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carl Zeiss Meditec AG Momentum Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Momentum Rank falls into.


XSWX:AFX
70GF Score
Carl Zeiss Meditec AG XSWX:AFX
Momentum Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Momentum Rank →
What does a Momentum Rank of 2 mean?
Carl Zeiss Meditec AG (XSWX:AFX) has a Momentum Rank of 2 as of Aug. 01, 2026. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on Carl Zeiss Meditec AG and its competitors. This is 60% below median its historical median of 5.00. Over the past decade, Carl Zeiss Meditec AG's Momentum Rank has ranged from 1.00 to 10.00.
Is Carl Zeiss Meditec AG's Momentum Rank too high?
Carl Zeiss Meditec AG's current Momentum Rank of 2 is 60% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Carl Zeiss Meditec AG has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Momentum Rank compare to ISRG and BDX?
Carl Zeiss Meditec AG's Momentum Rank of 2 can be compared against companies in the Medical Devices & Instruments industry. Historically, Carl Zeiss Meditec AG's own Momentum Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Momentum Rank for a Medical Devices & Instruments company?
A good Momentum Rank depends on the Medical Devices & Instruments industry context. However, Momentum Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Momentum Rank mean?
A high Momentum Rank can signal that a stock is expensive relative to its fundamentals. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on Carl Zeiss Meditec AG and its competitors. Carl Zeiss Meditec AG's current Momentum Rank is 2, which is 60% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Carl Zeiss Meditec AG (XSWX:AFX) has a current Momentum Rank of 2. The stock's GF Value™ is CHF66.33, compared to a current price of CHF27.56 — trading 58.5% below its estimated fair value. The current Momentum Rank is 2, which is 60% below median its 10-year median of 5.00. Carl Zeiss Meditec AG's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Momentum Rank calculated?
Momentum Rank is calculated from a company's financial statements. For Carl Zeiss Meditec AG (XSWX:AFX), the current Momentum Rank is 2 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of CHF27.56 is trading 58.5% below its estimated GF Value™ of CHF66.33.

Key valuation signals for XSWX:AFX:

  • Momentum Rank: 2 (60% below median its 10-year median of 5.00)
  • GF Value™: CHF66.33 vs. price of CHF27.56 (58.5% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
70GF Score

Get the complete analysis for XSWX:AFX

Momentum Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF27.56
Price
CHF66.33
GF Value